120 related articles for article (PubMed ID: 34984581)
1. Correction to: Epithelioid inflammatory myofibroblastic sarcoma with VCL-ALK fusion of central nervous system: case report and brief review of the literature.
Chopra S; Maloney N; Wang WL
Brain Tumor Pathol; 2022 Jan; 39(1):43. PubMed ID: 34984581
[No Abstract] [Full Text] [Related]
2. Epithelioid inflammatory myofibroblastic sarcoma with VCL-ALK fusion of central nervous system: case report and brief review of the literature.
Chopra S; Maloney N; Wang WL
Brain Tumor Pathol; 2022 Jan; 39(1):35-42. PubMed ID: 34743247
[TBL] [Abstract][Full Text] [Related]
3. Primary epithelioid inflammatory myofibroblastic sarcoma of the brain with EML4::ALK fusion mimicking intra-axial glioma: a case report and brief literature review.
Kim EE; Park CK; Kang KM; Kwak Y; Park SH; Won JK
J Pathol Transl Med; 2024 May; 58(3):141-145. PubMed ID: 38766740
[TBL] [Abstract][Full Text] [Related]
4. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.
Lee JC; Li CF; Huang HY; Zhu MJ; Mariño-Enríquez A; Lee CT; Ou WB; Hornick JL; Fletcher JA
J Pathol; 2017 Feb; 241(3):316-323. PubMed ID: 27874193
[TBL] [Abstract][Full Text] [Related]
5. A case report of epithelioid inflammatory myofibroblastic sarcoma with RANBP2-ALK fusion gene treated with the ALK inhibitor, crizotinib.
Kimbara S; Takeda K; Fukushima H; Inoue T; Okada H; Shibata Y; Katsushima U; Tsuya A; Tokunaga S; Daga H; Okuno T; Inoue T
Jpn J Clin Oncol; 2014 Sep; 44(9):868-71. PubMed ID: 25028698
[TBL] [Abstract][Full Text] [Related]
6. Epithelioid inflammatory myofibroblastic sarcoma of stomach: diagnostic pitfalls and clinical characteristics.
Xu P; Shen P; Jin Y; Wang L; Wu W
Int J Clin Exp Pathol; 2019; 12(5):1738-1744. PubMed ID: 31933992
[TBL] [Abstract][Full Text] [Related]
7. Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcoma.
Jiang Q; Tong HX; Hou YY; Zhang Y; Li JL; Zhou YH; Xu J; Wang JY; Lu WQ
Orphanet J Rare Dis; 2017 May; 12(1):97. PubMed ID: 28535796
[TBL] [Abstract][Full Text] [Related]
8. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
[TBL] [Abstract][Full Text] [Related]
9. Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature.
Liu Q; Kan Y; Zhao Y; He H; Kong L
Int J Clin Exp Pathol; 2015; 8(11):15328-32. PubMed ID: 26823889
[TBL] [Abstract][Full Text] [Related]
10. Epithelioid inflammatory myofibroblastic sarcoma in abdominal cavity: a case report and review of literature.
Wu H; Meng YH; Lu P; Ning HY; Hong L; Kang XL; Duan MG
Int J Clin Exp Pathol; 2015; 8(4):4213-9. PubMed ID: 26097614
[TBL] [Abstract][Full Text] [Related]
11. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
Parker BM; Parker JV; Lymperopoulos A; Konda V
J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
[TBL] [Abstract][Full Text] [Related]
12. Epithelioid Inflammatory Myofibroblastic Sarcoma of the Ovary With RANB2-ALK Fusion: Report of a Case.
Fang H; Langstraat CL; Visscher DW; Folpe AL; Schoolmeester JK
Int J Gynecol Pathol; 2018 Sep; 37(5):468-472. PubMed ID: 28787324
[TBL] [Abstract][Full Text] [Related]
13. Cytopathologic features of epithelioid inflammatory myofibroblastic sarcoma with correlation of histopathology, immunohistochemistry, and molecular cytogenetic analysis.
Lee JC; Wu JM; Liau JY; Huang HY; Lo CY; Jan IS; Hornick JL; Qian X
Cancer Cytopathol; 2015 Aug; 123(8):495-504. PubMed ID: 26139079
[TBL] [Abstract][Full Text] [Related]
14. Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.
Yu L; Liu J; Lao IW; Luo Z; Wang J
Diagn Pathol; 2016 Jul; 11(1):67. PubMed ID: 27460384
[TBL] [Abstract][Full Text] [Related]
15. ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report.
Xu X; Li H; Peng K; Yu Y; Chen L; Fang Y; Sun Y; Hou Y; Liu T
Oncol Lett; 2019 Feb; 17(2):2370-2376. PubMed ID: 30675302
[TBL] [Abstract][Full Text] [Related]
16. A case report on epithelioid inflammatory myofibroblastic sarcoma in the abdominal cavity.
Zhang S; Wang Z
Int J Clin Exp Pathol; 2019; 12(10):3934-3939. PubMed ID: 31933785
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary epithelioid inflammatory myofibroblastic sarcoma with multiple bone metastases: case report and review of literature.
Fu X; Jiang J; Tian XY; Li Z
Diagn Pathol; 2015 Jul; 10():106. PubMed ID: 26178751
[TBL] [Abstract][Full Text] [Related]
18. Epithelioid inflammatory myofibroblastic sarcoma: a case report.
Sarmiento DE; Clevenger JA; Masters GA; Bauer TL; Nam BT
J Thorac Dis; 2015 Oct; 7(10):E513-6. PubMed ID: 26623133
[TBL] [Abstract][Full Text] [Related]
19. Posttransplant epithelioid inflammatory myofibroblastic sarcoma: A case report.
Garg R; Kaul S; Arora D; Kashyap V
Indian J Pathol Microbiol; 2019; 62(2):303-305. PubMed ID: 30971562
[TBL] [Abstract][Full Text] [Related]
20. 'ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma'.
J Pathol; 2017 Jun; 242(2):260. PubMed ID: 28543105
[No Abstract] [Full Text] [Related]
[Next] [New Search]